The American Gastroenterological Association (AGA) has released a comprehensively updated clinical guideline on the ...

In its new guideline, the AGA recommends infliximab, adalimumab, ustekinumab, risankizumab, mirikizumab, guselkumab or ...

Sold in pill form, the JAK inhibitor Rinvoq (upadacitinib) offers a new, fast-acting alternative to infusions and injectable drugs. On May 18, the U.S. Food and Drug Administration (FDA) granted ...

Common medications used to treat Crohn’s, such as 5-aminosalycates, biologics, steroids, and JAK inhibitors, can cause unwanted side effects. Medications for Crohn’s disease can reduce inflammation, ...

Ontunisertib could become the first FDA-approved anti-fibrotic suitable for Crohn’s disease patients with symptomatic ...

The (AGA) has released a comprehensively updated clinical guideline on the pharmacological management of moderate-to-severe Crohn's disease.

Bhat: I love this question! Crohn’s disease treatment has progressed significantly in recent years, incorporating new mechanisms of action such as interleukin inhibitors and Janus kinase inhibitors.

Getting advanced treatment immediately after a Crohn’s disease diagnosis improves patient outcomes, according to a year-long study involving 386 people. The disease is a life-long inflammatory bowel ...

If you were recently diagnosed with Crohn’s disease, you probably have all kinds of questions about what comes next. One of the most overwhelming thoughts you may have post-diagnosis: Will I need to ...

Find out how much protein experts say you need to manage Crohn's disease effectively and which protein sources will best support gut health and repair.